Last reviewed · How we verify
NCT06325774
Radical Hypofractionated Radiotherapy for Localized Prostate Cancer
NA trial testing Hypofractionated radiation therapy in Localized Prostate Cancer in 20 participants. Currently enrolling.
1 September 2026
Quick facts
| Lead sponsor | Changhai Hospital |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 20 |
| Start date | 1 September 2024 |
| Primary completion | 1 September 2026 |
| Estimated completion | 1 September 2031 |
| Sites | 1 location across China |
Drugs / interventions tested
- Hypofractionated radiation therapy — full drug profile →
Conditions studied
- Localized Prostate Cancer — all drugs for Localized Prostate Cancer →
Sponsor
Changhai Hospital
Who can join
18 and older, male only, with Localized Prostate Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this trial is to study the safety outcomes of hypofractionated radiotherapy in treating patients with localized prostate cancer. Hypofractionated radiotherapy delivers higher doses of radiotherapy in a shorter time period, may enabling the killing of more tumor cells with fewer side effects. Accumulating evidence has proven the safety and feasibility of hypofractionated radiotherapy for localized prostate cancer.But for localized prostate cancer,the optimal dose per fraction of hypofractionated radiotherapy is still on its way.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Hypofractionated radiotherapy for localized prostate cancer: the protocol for a prospective clinical trial.
Liang Y, Zhang W, Zhao X, Zhang H. · · 2025 · PMID 40257456 · DOI 10.1080/14796694.2025.2489340
Verify or expand the search:
- PubMed search for NCT06325774
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Hypofractionated radiation therapy
Trials testing the same drug.
- NCT06325995 — Hypofractionated Post-prostatectomy Radiotherapy (HYPORT)for Localized Prostate Cancer · NA · recruiting
- NCT05775757 — SMC Radiation Oncology Breast Cancer Cohort Study · recruiting
- NCT04318717 — Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma · Phase 2 · recruiting
- NCT03212235 — Hypofractionated Radiation Therapy for Glioblastoma · Phase 2 · unknown
- NCT02206230 — Trial of Hypofractionated Radiation Therapy for Glioblastoma · Phase 2 · completed
Other recruiting trials for Localized Prostate Cancer
Currently open trials in the same condition.
- NCT06966778 — Oxybutynin ER to Promote Early Continence Recovery After Robotic Prostatectomy: A Randomized Controlled Trial · NA · recruiting
- NCT06825091 — Is Adaptive SBRT for Prostate vs Image-guided Radiotherapy a True Evolution (ASPIRE) · Phase 3 · recruiting
- NCT06117059 — The PRECISION Study: 3 Fractions of Prostate SBRT and RayPilot HypoCath Image Guidance · NA · recruiting
- NCT06362577 — Clinical Study of HIFU for Localized Prostate Cancer · recruiting
- NCT06325995 — Hypofractionated Post-prostatectomy Radiotherapy (HYPORT)for Localized Prostate Cancer · NA · recruiting
Other Changhai Hospital trials
Trials by the same sponsor.
- NCT07490002 — Neoadjuvant Therapy With Iparomlimab and Tuvonralimab, Lenvatinib and Chemotherapy in Resectable ESCC · Phase 2 · not yet recruiting
- NCT07464392 — FMT for the Prevention of Infectious Complications in Patients With Moderately Severe and Severe Acute Pancreatitis · NA · recruiting
- NCT07507071 — Comparison of the Sensitivity of pCLE and Pathological Biopsy for Gastric Mucosal Lesions · not yet recruiting
- NCT07481591 — Capsule Endoscopy in GI Bleeding: A Retrospective Study · not yet recruiting
- NCT07439757 — AI-Powered Precision Decision-Making for Pancreatic Diseases · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06325774 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Changhai Hospital
- Last refreshed: 26 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06325774.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing